MedTrace Logo

Effects of Telemonitoring Service for Obesity Care

NCT01344811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 661

Last updated 2020-01-31

No results posted yet for this study

Summary

A randomized, open, parallel, multi-center trial to evaluate weight loss efficacy of Smart Care Service in obese patients with metabolic syndrome.

Conditions

Interventions

PROCEDURE

Telemonitoring

The Telemonitoring group will be provided the Smartphone, body composition analyzer and pedometer. They should visit the site once per every 3 months (12 weeks), and measure their body composition during study period. After measurement of body composition, the subjects should make transmit measured information through Smartphone into a centralized server of Smart Care Center. At Smart care Center, care manager will provide remote body composition and activity monitoring and individual obesity case management

OTHER

control group

The control group will receive a weighting scale and pedometer. They should perform the same weight measurement (minimum three times a week) like the intervention group during the study, and measured results should be recorded in a diary of self body weight and the number of steps. In addition, the subjects should visit the site once per every three months (12 weeks).

Sponsors & Collaborators

  • LG Electronics Inc.

    collaborator INDUSTRY

  • Purdue University

    collaborator OTHER

  • Chang Hee, Lee

    lead INDUSTRY

Principal Investigators

  • Bi-Ryong Cho · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-03-31
Completion
2013-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344811 on ClinicalTrials.gov